Structural reorganization of the chromatin remodeling enzyme Chd1 upon engagement with nucleosomes
Abstract
The yeast Chd1 protein acts to position nucleosomes across genomes. Here we model the structure of the Chd1 protein in solution and when bound to nucleosomes. In the apo state the DNA binding domain contacts the edge of the nucleosome while in the presence of the non-hydrolyzable ATP analog, ADP-beryllium fluoride, we observe additional interactions between the ATPase domain and the adjacent DNA gyre 1.5 helical turns from the dyad axis of symmetry. Binding in this conformation involves unravelling the outer turn of nucleosomal DNA and requires substantial reorientation of the DNA binding domain with respect to the ATPase domains. The orientation of the DNA-binding domain is mediated by sequences in the N-terminus and mutations to this part of the protein have positive and negative effects on Chd1 activity. These observations indicate that the unfavourable alignment of C-terminal DNA binding region in solution contributes to an auto-inhibited state.
Data availability
-
Chd1-nuc-engagedPublicly available at the Electron Microscopy Data Bank (accession no. EMDB-3502).
-
Chd1 Nuc SeqPublicly available at the EMBL European Archive (accession no: PRJEB15701).
-
Chd1-nuc apoPublicly available at the Electron Microscopy Data Bank (accession no. EMDB-3517).
-
Data from: Structural reorganization of the chromatin remodeling enzyme Chd1 upon engagement with nucleosomesAvailable at Dryad Digital Repository under a CC0 Public Domain Dedication.
-
SAXSPublicly available at the Small Angle Scattering Biological Data Bank (accession no. SASDBU7).
-
SAXSPublicly available at the Small Angle Scattering Biological Data Bank (accession no. SASDBV7).
-
SAXSPublicly available at the Small Angle Scattering Biological Data Bank (accession no. SASDBW7).
-
SAXSPublicly available at the Small Angle Scattering Biological Data Bank (accession no. SASDBX7).
-
SAXSPublicly available at the Small Angle Scattering Biological Data Bank (accession no. SASDBY7).
Article and author information
Author details
Funding
Wellcome (95062)
- Ramasubramanian Sundaramoorthy
- Amanda L Hughes
- Vijender Singh
- Nicola Wiechens
- Tom Owen-Hughes
Wellcome (097945/B/11/Z)
- Ramasubramanian Sundaramoorthy
- Amanda L Hughes
- Vijender Singh
- Nicola Wiechens
- Tom Owen-Hughes
Wellcome (099149/Z/12/Z)
- Ramasubramanian Sundaramoorthy
- Hassane El-Mkami
- David G Norman
- Tom Owen-Hughes
Wellcome (97945)
- Ramasubramanian Sundaramoorthy
- Amanda L Hughes
- Nicola Wiechens
- Daniel P Ryan
- David G Norman
- Tom Owen-Hughes
European Molecular Biology Organization (ALTF 380-2015)
- Amanda L Hughes
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2017, Sundaramoorthy et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 3,147
- views
-
- 762
- downloads
-
- 51
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
Pancreatic KATP channel trafficking defects underlie congenital hyperinsulinism (CHI) cases unresponsive to the KATP channel opener diazoxide, the mainstay medical therapy for CHI. Current clinically used KATP channel inhibitors have been shown to act as pharmacochaperones and restore surface expression of trafficking mutants; however, their therapeutic utility for KATP trafficking-impaired CHI is hindered by high affinity binding, which limits functional recovery of rescued channels. Recent structural studies of KATP channels employing cryo-electron microscopy (cryoEM) have revealed a promiscuous pocket where several known KATP pharmacochaperones bind. The structural knowledge provides a framework for discovering KATP channel pharmacochaperones with desired reversible inhibitory effects to permit functional recovery of rescued channels. Using an AI-based virtual screening technology AtomNet followed by functional validation, we identified a novel compound, termed Aekatperone, which exhibits chaperoning effects on KATP channel trafficking mutations. Aekatperone reversibly inhibits KATP channel activity with a half-maximal inhibitory concentration (IC50) ~9 μM. Mutant channels rescued to the cell surface by Aekatperone showed functional recovery upon washout of the compound. CryoEM structure of KATP bound to Aekatperone revealed distinct binding features compared to known high affinity inhibitor pharmacochaperones. Our findings unveil a KATP pharmacochaperone enabling functional recovery of rescued channels as a promising therapeutic for CHI caused by KATP trafficking defects.
-
- Microbiology and Infectious Disease
- Structural Biology and Molecular Biophysics
Giant viruses of protists are a diverse and likely ubiquitous group of organisms. Here, we describe Jyvaskylavirus, the first giant virus isolated from Finland. This clade B marseillevirus was found in Acanthamoeba castellanii from a composting soil sample in Jyväskylä, Central Finland. Its genome shares similarities with other marseilleviruses. Helium ion microscopy and electron microscopy of infected cells unraveled stages of the Jyvaskylavirus life cycle. We reconstructed the Jyvaskylavirus particle to 6.3 Å resolution using cryo-electron microscopy. The ~2500 Å diameter virion displays structural similarities to other Marseilleviridae giant viruses. The capsid comprises of 9240 copies of the major capsid protein, encoded by open reading frame (ORF) 184, which possesses a double jellyroll fold arranged in trimers forming pseudo-hexameric capsomers. Below the capsid shell, the internal membrane vesicle encloses the genome. Through cross-structural and -sequence comparisons with other Marseilleviridae using AI-based software in model building and prediction, we elucidated ORF142 as the penton protein, which plugs the 12 vertices of the capsid. Five additional ORFs were identified, with models predicted and fitted into densities that either cap the capsomers externally or stabilize them internally. The isolation of Jyvaskylavirus suggests that these viruses may be widespread in the boreal environment and provide structural insights extendable to other marseilleviruses.